Reviva Pharmaceuticals Holdings (RVPH)

Reviva Pharmaceuticals Holdings on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on OTC.

Download CSV

400K

Short interest

settlement 2026-10-15

8.0

Days to cover

-4.1 days vs prior

49.8%

Short share of volume

2026-05-13

185

Fails to deliver

settlement 2026-10-06

Thu 12 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-10-15.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in RVPH is 400,229 shares, down 4,853 shares over the last month. Over the last 48 readings it ranged from 400,229 shares (15 October 2026) to 25,643,875 shares (15 December 2025). The latest reading sits at the bottom of that range. At the reported average volume of 50K shares a day that is 8.0 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/rvph" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	400,229	-0.4%	50,207	7.97
2026-09-30	401,987	-0.8%	33,359	12.05
2026-09-15	405,082	+1.2%	53,867	7.52
2026-08-31	400,267	-0.0%	52,711	7.59
2026-08-14	400,313	-2.1%	56,098	7.14
2026-07-31	408,776	-4.2%	120,807	3.38
2026-07-15	426,525	-14.1%	114,930	3.71
2026-06-30	496,237	-13.8%	111,730	4.44
2026-06-15	575,626	-15.4%	289,871	1.99
2026-05-29	680,054	-44.2%	433,367	1.57
2026-05-15	1,217,792	-34.7%	1,655,772	1.00
2026-04-30	1,866,151	+30.6%	381,005	4.90
2026-04-15	1,429,477	-22.1%	733,386	1.95
2026-03-31	1,834,224	+126.6%	1,429,491	1.28
2026-03-13	809,588	-95.9%	254,944	3.18
2026-02-27	19,875,318	-10.0%	3,213,729	6.18
2026-02-13	22,084,637	-6.7%	2,202,611	10.03
2026-01-30	23,679,332	+0.5%	3,084,032	7.68
2026-01-15	23,573,577	+9.8%	4,863,659	4.85
2025-12-31	21,464,180	-16.3%	10,754,569	2.00
2025-12-15	25,643,875	+10.8%	5,473,883	4.68
2025-11-28	23,151,800	+0.3%	2,919,387	7.93
2025-11-14	23,072,984	+3.1%	4,251,058	5.43
2025-10-31	22,384,162	+0.5%	10,383,362	2.16
2025-10-15	22,270,955	+60.7%	26,075,975	1.00
2025-09-30	13,860,222	+6.5%	11,371,796	1.22
2025-09-15	13,010,726	-0.8%	893,070	14.57
2025-08-29	13,114,004	+13.0%	1,862,478	7.04
2025-08-15	11,607,591	-2.9%	2,617,924	4.43
2025-07-31	11,951,705	+97.5%	2,801,260	4.27
2025-07-15	6,050,915	+69.1%	3,291,932	1.84
2025-06-30	3,578,734	+4.0%	4,156,027	1.00
2025-06-13	3,442,601	+5.1%	652,857	5.27
2025-05-30	3,276,025	+7.8%	647,293	5.06
2025-05-15	3,040,497	-9.7%	374,248	8.12
2025-04-30	3,366,693	-11.7%	432,859	7.78
2025-04-15	3,814,339	+30.5%	1,332,805	2.86
2025-03-31	2,922,042	+2.5%	498,424	5.86
2025-03-14	2,849,403	-24.8%	795,071	3.58
2025-02-28	3,789,692	-10.8%	1,255,042	3.02
2025-02-14	4,249,301	-15.7%	1,620,161	2.62
2025-01-31	5,038,470	-3.5%	1,591,704	3.17
2025-01-15	5,221,720	-7.5%	3,215,188	1.62
2024-12-31	5,644,143	-35.8%	5,447,755	1.04
2024-12-13	8,796,871	+42.8%	4,994,246	1.76
2024-11-29	6,160,358	-4.2%	425,872	14.47
2024-11-15	6,431,780	+21.4%	976,163	6.59
2024-10-31	5,297,424	-0.2%	363,303	14.58

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 13 May 2026, the short share of RVPH volume is 49.8%, up 2.9 points over the last five sessions. Over the last 30 readings it ranged from 27.6% (10 April 2026) to 74.6% (7 April 2026). The latest reading is 5.4 points below the 30-session average of 55.2%, on 7.5M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-05-13	3.7M	7.5M	49.8%	471,684
2026-05-12	69K	118K	58.4%	0
2026-05-11	157K	282K	55.8%	0
2026-05-08	93K	172K	53.7%	0
2026-05-07	52K	117K	44.2%	0
2026-05-06	79K	169K	46.9%	8,198
2026-05-05	168K	449K	37.3%	24,047
2026-05-04	103K	164K	62.7%	0
2026-05-01	78K	122K	64.2%	0
2026-04-30	45K	157K	28.6%	3
2026-04-29	82K	154K	53.3%	0
2026-04-28	120K	190K	63.2%	0
2026-04-27	54K	107K	50.5%	0
2026-04-24	60K	124K	48.1%	18,625
2026-04-23	127K	172K	73.6%	0
2026-04-22	131K	278K	47.2%	0
2026-04-21	140K	215K	65.3%	0
2026-04-20	112K	174K	64.4%	0
2026-04-17	207K	523K	39.6%	3
2026-04-16	178K	288K	62.0%	0
2026-04-15	110K	209K	52.9%	30
2026-04-14	241K	373K	64.6%	0
2026-04-13	300K	471K	63.7%	39,848
2026-04-10	83K	300K	27.6%	1,621
2026-04-09	154K	250K	61.4%	250
2026-04-08	140K	238K	58.9%	0
2026-04-07	338K	453K	74.6%	6,065
2026-04-06	251K	424K	59.3%	8,081
2026-04-02	552K	1.0M	52.6%	0
2026-04-01	274K	380K	72.0%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 6 October 2026, the fails-to-deliver balance in RVPH is 185 shares, up 183 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (9 June 2026) to 679,215 shares (14 May 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-06	185	$0.51	$94
2026-09-17	2	$0.49	$1
2026-09-03	252	$0.54	$136
2026-09-02	368	$0.51	$188
2026-07-10	19	$0.54	$10
2026-07-07	23	$0.63	$14
2026-07-06	5,914	$0.66	$4K
2026-07-02	7,040	$0.66	$5K
2026-07-01	8,208	$0.63	$5K
2026-06-30	1,289	$0.65	$838
2026-06-25	44	$0.67	$29
2026-06-15	471	$0.68	$320
2026-06-09	2	$0.69	$1
2026-06-08	1,571	$0.72	$1K
2026-06-05	81	$0.61	$49
2026-06-01	3	$0.41	$1
2026-05-29	101	$0.43	$43
2026-05-22	83	$0.42	$35
2026-05-20	15	$0.41	$6
2026-05-19	2,611	$0.41	$1K
2026-05-18	517	$0.33	$171
2026-05-15	61,318	$0.39	$24K
2026-05-14	679,215	$0.35	$238K
2026-05-12	3,791	$0.80	$3K
2026-05-08	3,644	$0.86	$3K
2026-05-06	6,512	$0.82	$5K
2026-05-05	3	$0.84	$3
2026-05-04	7,549	$0.88	$7K
2026-05-01	8,503	$0.87	$7K
2026-04-30	157	$0.87	$137

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for RVPH in the last 90 days. The most recent filings are listed below. Latest filing: Patel Purav (Director) on 2022-11-18.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2022-11-18	Patel Purav	Director	Buy	3K	$4.69	$14K	44K
2022-09-30	Narayan Prabhu	Chief Financial Officer	Buy	50K	$1.66	$83K	100K
2022-06-30	Narayan Prabhu	Chief Financial Officer	Buy	50K	$1.21	$61K	50K
2021-06-01	Vedanta Associates-R, LP	TenPercentOwner	Buy	399K	$3.75	$1.5M	399K
2021-06-01	Vedanta Associates-R, LP	TenPercentOwner	Buy	931K	$3.75	$3.5M	931K
2020-12-14	SAXENA PARAG	Director,TenPercentOwner	Grant	198K	price not stated in the filing	not stated	2.1M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

4 holders report 5% or more of RVPH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Integrated Core Strategies (US) LLC at 8.2% of the class (1,072,690 shares), filed 2026-08-03 for an event on 2026-06-30.

Filed	Form	Holder	Shares	Of class	Event
2026-08-13	13G/Ano. 1	Barclays PLCparent holding company	20	0.0%	2026-06-30
2026-08-03	13G/Ano. 1	Integrated Core Strategies (US) LLCother entity	1.1M	8.2%	2026-06-30
2026-08-03	13G/Ano. 1	Millennium Management LLCother entity	1.1M	8.2%	2026-06-30
2026-08-03	13G/Ano. 1	Millennium Group Management LLCother entity	1.1M	8.2%	2026-06-30
2026-08-03	13G/Ano. 1	Israel A. Englanderindividual	1.1M	8.2%	2026-06-30
2026-07-31	13G/Ano. 1	UBS Group AGbank	0	0.0%	2026-06-30
2026-05-15	13G/Ano. 1	CVI Investments, Inc.corporation	673K	4.9%	2026-03-31
2026-05-15	13G/Ano. 1	Heights Capital Management, Inc.corporation	673K	4.9%	2026-03-31
2026-03-24	13D/Ano. 13	Parag Saxenaindividual	363K	2.8%	2026-03-20
2026-02-17	13G/Ano. 1	683 CAPITAL MANAGEMENT, LLCinvestment adviser	3.5M	3.0%	2025-12-31
2026-02-17	13G/Ano. 1	Zweiman Ariindividual	3.5M	3.0%	2025-12-31
2026-02-17	13G/Ano. 1	683 CAPITAL PARTNERS, LPpartnership	3.5M	3.0%	2025-12-31
2025-12-22	13D/Ano. 12	VEDANTA PARTNERS, LLCother entity	5.4M	4.4%	2025-12-18
2025-09-24	13D/Ano. 6	Bhat Laxminarayanindividual	3.7M	3.8%	2025-09-22

What this page is

Reviva Pharmaceuticals Holdings in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Reviva Pharmaceuticals Holdings (RVPH), SEC CIK 1742927, listed on OTC. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-05-13.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-06.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-13.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2022-11-18.JSON and CSV
Company record: EDGAR filing index for CIK 1742927Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of RVPH is sold short?

400,229 shares were held short at the 2026-10-15 settlement, 8.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is RVPH's daily short volume?

On 2026-05-13, 3,734,662 of the 7,493,424 RVPH shares reported to FINRA were sold short, 49.8% of the day's reported volume. Short volume is a flow for one day, not a position.

Does RVPH have fails to deliver?

The SEC's latest file shows 185 RVPH shares failed to deliver at settlement 2026-10-06. Fails are reported per settlement date and published twice a month with a lag.

Are RVPH insiders buying or selling?

No open-market insider trades were reported for RVPH in the last 90 days. The most recent filings are listed below. Latest filing: Patel Purav (Director) on 2022-11-18.

Who owns 5% or more of RVPH?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Reviva Pharmaceuticals Holdings (RVPH)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

Reviva Pharmaceuticals Holdings in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions